Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension

American Heart Journal

Volumn 135, Issue 1, 1998, Pages 58-66

  Muscholl, M W ^a   Schunkert, H ^a   Muders, F ^a   Elsner, D ^a   Kuch, B ^a   Hense H , W ^a   Riegger, G A J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; RENIN;

ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 0031930133     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70343-6     Document Type: Article

References (52)

1. D Levy RJ Garrison DD Savage WB Kannel WP. Castelli Prognostic implications of echocardiographically determined LV mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
2. JM Sullivan R van der Zwaag F El-Zeky KB Ramaanathan DM. Mirvis LV hypertrophy: Effect on survival J Am Coll Cardiol 22 1993 508 513
3. WS Post MG Larson D. Levy Impact of LV structure on the incidence of hypertension Circulation 90 1994 179 185
4. H Iso M Kiyama M Doi LV mass and subsequent blood pressure changes among middle aged men in rural and urban Japanese populations Circulation 89 1994 1717 1724
5. MJ Koren RB Devereux PN Casale DD Savage JH. Laragh Relation of LV mass and geometry to morbidity in uncomplicated essential hypertension Ann Intern Med 114 1991 345 352
6. AC Pearson C Gudipati D Nagelhout J Sear JD Cohen A. Labovitz Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension J Am Coll Cardiol 17 1991 422 430
7. A Ganau RB Devereux R Roman Patterns of LV hypertrophy and geometric remodeling in essential hypertension J Am Coll Cardiol 19 1992 1550 1558
8. HM Krumholz M Larson D. Levy Prognosis of LV geometric patterns in the Framingham Heart Study J Am Coll Cardiol 25 1995 879 884
9. AJG Riegger G Liebau M Holzschuh D Witkowski H Steinler K. Kochsiek Role of angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting enzyme blockade Am J Cardiol 53 1984 614 618
10. K Swedberg P Eneroth J Kjekhus L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality Circulation 82 1990 1730 1736
11. EP Kromer GA. Riegger Effects of long term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat Am J Cardiol 62 1988 161 163
12. H Schunkert B Jackson SS Tang Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts Circulation 87 1993 1328 1339
13. KT Weber CG. Brilla Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1991 1848 1865
14. FI Schunkert JI Sandoshima T Cornelius Angiotensin II induced growth responses in isolated adult rat hearts. Evidence for load independent induction of cardiac protein synthesis by angiotensin II Circ Res 76 1995 489 497
15. H Schunkert HW Hense SR Holmer Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and LV hypertrophy N Engl J Med 330 1994 1634 1638
16. X Jeunemaitre F Soubrier YV Kotelevtsev Molecular basis of human hypertension: role of angiotensinogen Cell 71 1992 169 180
17. A Jamieson D Murdoch JA Kennedy JM. Connell LV mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism J Hypertens 13 1995 551 556
18. D Sahn A DeMaria J Kisslo A. Weyman The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantification in M-mode echocardiography. Results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
19. WH. Gaasch LV radius to wall thickness ratio Am J Cardiol 43 1979 1189 1194
20. JW Helak N. Reichek Quantification of human left mass and volume by two-dimensional echocardiography: in vitro anatomic validation Circulation 63 1981 1398 1407
21. N Reichek J Helak T Plappert MJ Sutton KT. Weber Anatomical validation of LV mass estimates from clinical two-dimensional echocardiography: initial results Circulation 67 1983 348 352
22. M Muscholl K Dennig F Kraus W. Rudolph Echocardiographic and Doppler echocardiographic characterization of LV diastolic function Herz 15 1990 377 392
23. D Levy KM Anderson DD Savage WB Kannel JC Christiansen WP. Castelli Echocardiographically detected LV hypertrophy: prevalence and risk factors Ann Intern Med 108 1988 7 13
24. HF Kücherer W Kübler Diagnosis of LV hypertrophy by echocardiography J Cardiovasc Pharmacol 19 suppl 5 1992 S81 S86
25. DD Savage RJ Garrison WB. Kannel The spectrum of LV hypertrophy in a general population sample: the Framingham Study Circulation 75 suppl I 1987 I-26 I-33
26. GAJ Riegger D Elsner EP Kromer Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects Circulation 77 1988 398 406
27. P Verdecchia G Schillaci C Borgioni Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal LV mass J Am Coll Cardiol 25 1995 871 878
28. AC Pearson Ch Gudipati D Nagelhout J Seare JD Cohen AJ. Labovitz Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension J Am Coll Cardiol 17 1991 422 430
29. PA Khairallah J. Kanabus Angiotensin and myocardial protein synthesis Perspect Cardiovasc Res 8 1983 337 347
30. JI Sandoshima S. Izumo Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocites and hyperplasia of cardiac fibroblasts: critical role of the AT 1 receptor subtype Circ Res 73 1993 905 921
31. H Schunkert EO Weinberg G Bruckschlegel Alterations of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding J Clin Invest 96 1995 2768 2774
32. AM. Katz Angiotensin II: hemodynamic regulator or growth factor? J Mol Cell Cardiol 22 1990 739 747
33. DA Duprez FR Bauwens ML De Buyzere Influence of arterial blood pressure and aldosterone on LV hypertrophy in moderate essential hypertension Am J Cardiol 71 1993 17A 20A
34. C Lavides G Mayor J. Diez Association of cardiovascular risk factors in hypertensive patients with LV hypertrophy Rev Clin Esp 189 1991 403 407
35. CM Erley M Hozer BK Krämer T. Risler Renal hemodynamics and organ damage in young hypertensive patients with different plasma renin activities after ACE inhibition Nephrol Dial Transplant 7 1992 216 220
36. E Herrold M Jason JS Borer RB Devereux TD Pickering JH. Laragh Volume vs. renin dependent forms of hypertension [abstract] Clin Res 31 1986 688A
37. R Marcus L Krause AB Weder A Dominguez-Mejia NJ Schorck A. Julius Sex-specific determinants of increased LV mass in the Tecumseh Blood Pressure Study Circulation 90 1994 928 936
38. JS Gottdiener DJ Reda BJ Matterson BM Massie A Notargiacomo RJ Hamburger Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents J Am Coll Cardiol 24 1994 1492 1498
39. RB Devereux DD Savage JM Drayer JH. Laragh LV hypertrophy and function in high-, normal-, and low renin forms of essential hypertension Hypertension 4 1982 524 531
40. DD Savage D Levy AL Dannenberg RJ Garrison WP. Castelli Association of echocardiographic LV mass with body size, blood pressure and physical activity (The Framingham Study) Am J Cardiol 65 1990 371 376
41. G DeSimone RB Devereux MJ Roman Y Schlussel MH Alderman JH. Laragh Echocardiographic LV mass and electrolyte intake predict arterial hypertension Ann Int Med 114 1991 202 209
42. G DeSimone RB Devereux S Chien MH Alderman SA Atlas JH. Laragh Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal subjects Circulation 81 1990 107 117
43. RE Schmieder FJ Messerli GE Garavaglia BD. Nunez Dietery salt intake: a determinant of cardiac involvement in essential hypertension Circulation 78 1988 951 956
44. A Ganau A Arm PS Saba Stroke volume and left heart anatomy in relation to plasma volume in essential hypertension J Hypertens 9 suppl 6 1991 S150 S151
45. T Suzuki H Abe S Nagata LV structural characteristics in unilateral renovascular hypertension and primary aldosteronism Am J Cardiol 62 1988 1224 1227
46. JR Ledsome N Wilson CA Courneya AJ. Rankin Release of atrial natriuretic peptide by atrial distension Can J Physiol Pharmacol 63 1986 739 744
47. GAJ Riegger EP Kromer S Wild H Hofbauer ML Klug K. Kochsiek Atrial natriuretic factor in acute and chronic cardiac failure J Cardiovasc Pharmacol 10 suppl 6 1987 S161 S165
48. P Dessi-Fulgheri R Palermo G di Noto V Conti A Baldinelli G Pupira High levels of plasma atrial natriuretic factor and impaired LV diastolic function in hypertensives without LV hypertrophy J Hypertens 10 1992 161 165
49. AR Lucarini S Favilla C Marini F Lattanzi M Urbani A. Salvetti Atrial natriuretic factor in essential hypertension: echocardiographic and humoral correlates Clin Cardiol 15 1992 353 356
50. CC Glembotsky JE Dixon TR. Gibson Secretion of arterial natriuretic factor by primary cardiac myocytes J Biol Chem 263 1988 16073 16081
51. A Ganau RB Devereux SA Atlas M Pecker MJ Roman P. Vargin Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function, and systemic hemodynamics J Am Coll Cardiol 14 1989 715 724
52. R Garcia G Thibault M. Cantin Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat Biochem Biophys Res Comm 145 1987 211 217